Dear Colleague,

Now in its 11th year, Scottsdale Interventional Forum, SIF 2015 will continue to provide attendees a robust and comprehensive review of state-of-the-art patient care. As there are rapid technological advances in cardiovascular medicine, a case-based approach will be utilized to provide our attendees a rich educational experience. In keeping with our tradition, SIF 2015 will utilize a world-class faculty with a profound understanding of pathophysiologic mechanisms of disease, the most current published literature and the most innovative treatment options. This extraordinary faculty provides a powerful and sound educational experience for physicians, nurses and allied cardiovascular professionals. Multiple live cases broadcast from leading centers throughout the U.S. will provide the practical application of what was debated in the Forum’s didactic sessions. Over the past decade, the unique appeal and extraordinary faculty of SIF have led to the Forum’s growth, which now includes international participation in attendees and faculty as well as live case transmissions.

SIF 2015 will include a number of workshops and symposia covering device selection and management of CTOs, complex bifurcations, left main disease and other complex coronary subsets. The coronary sessions will also include a detailed review of new DES platforms ranging from those devices with durable or biodegradable polymers to those DES which are built on a completely biodegradable platform. The sessions will include a review of adjunctive coronary imaging, coronary physiology, pharmacologic therapies, hemodynamic support and appropriateness criteria. These important symposia will be conducted by experts in the field, to whom our attendees will have direct access throughout the four days of SIF.

Given the rapid evolution of transcatheter therapies for structural heart disease, SIF 2015 will devote both didactic sessions as well as satellite live cases from leading centers throughout the world. Included in these sessions and live case transmissions will be transcatheter aortic valve replacement, left atrial therapeutics and renal denervation. In addition, a first-of-its-kind transcatheter mitral valve live case is planned.

In summary, the primary objective of SIF 2015 is to provide attendees with the knowledge and skills to improve bedside management of complex coronary disease as well as apply in a very practical way the newest, most innovative technologies in cardiovascular medicine. All of this is intended to provide a rich educational experience, open access and interaction with a world-class faculty, the ultimate goal being improvement in patient care and procedural outcomes.

We look forward to seeing you in beautiful Scottsdale, Arizona at the 2015 Scottsdale Interventional Forum!

Sincerely, SIF Symposium Directors

David G. Rizik,


Chief Scientific Officer

Scottsdale Lincoln Health Network

Co-Director Interventional Cardiology

Scottsdale Healthcare Hospitals

Scottsdale, Arizona

Mark Reisman,


Section Head, Interventional Cardiology

and Director, Structural Heart Services,

UW Medicine Regional Heart Center

Clinical Professor of Medicine,

University of Washington

President, Seattle Science Foundation

Seattle, Washington

James B. Hermiller,


Director, Interventional Cardiology

Director, Interventional Cardiology Fellowship

St. Vincent Heart Center

Indianapolis, Indiana